Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Human Chorionic Gonadotropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Recipient : Genuine Research Center, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Human Chorionic Gonadotrophin is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 27, 2020
Lead Product(s) : Human Chorionic Gonadotropin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Recipient : Genuine Research Center, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable